Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals
Clinical Benefit
| Substantial |
Le service médical rendu par COSOPT 20 mg/5 ml/ml, collyre en solution en récipient unidose, est important.
|
Clinical Added Value
| no clinical added value |
COSOPT 20 mg/5 mg/ml, collyre en solution en récipient unidose, n'apporte pas d'amélioration du service médical rendu (niveau V) par rapport COSOPT, collyre en solution en flacon multidose.
|
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
QeESY1RyP9BPa2mR
